Connect Biopharma Holdings Ltd - CNTB
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Nov 03, 2026 | SCHEDULE 13G/A | Qiming Managing Directors Fund V, L.P. | 0.1% | 54,826 | View |
| Nov 03, 2026 | SCHEDULE 13G/A | Qiming Venture Partners V, L.P. | 2.8% | 1,766,600 | View |
| Nov 03, 2026 | SCHEDULE 13G/A | Qiming Corporate GP V, Ltd. | 2.9% | 1,821,426 | View |
| Nov 03, 2026 | SCHEDULE 13G/A | Qiming GP V, L.P. | 2.8% | 1,766,600 | View |
| Nov 03, 2026 | SCHEDULE 13G/A | Qiming GP VII, LLC | 1.5% | 935,064 | View |
| Nov 03, 2026 | SCHEDULE 13G/A | Qiming Venture Partners VII, L.P. | 1.5% | 926,527 | View |
| Nov 03, 2026 | SCHEDULE 13G/A | Qiming VII Strategic Investors Fund, L.P. | 0.0% | 8,537 | View |
| Oct 06, 2026 | SCHEDULE 13G | BML Investment Partners, L.P. | 6.1% | 3,864,400 | View |
| Oct 06, 2026 | SCHEDULE 13G | Braden M Leonard | 6.77% | 4,264,400 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Ikarian Capital, LLC | 6.9% | 4,338,534 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Neil Shahrestani | 6.9% | 4,338,534 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Wei Zheng | 4.0% | 2,520,359 | View |
| May 15, 2026 | SCHEDULE 13G/A | Wei Zheng | 6.2% | 3,876,036 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.